Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Perrigo Plc's Business Segments
Perrigo Plc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2026
Reportable Segments
3
Largest Segment
Self Care
Total Revenue
$ 969
Regions Reported
1
Revenue Share by Reportable Segment - Q1 FY2026
- Self Care56.1%
- Specialty Care21.4%
- Infant Formula9.3%
Revenue by Reportable Segment - Q1 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Self Care | $ 543 | 56.1% |
| Specialty Care | $ 207 | 21.4% |
| Infant Formula | $ 90 | 9.3% |
Revenue Share by Region - Q1 FY2026
- Europe40.4%
Revenue by Geographic Region - Q1 FY2026
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Europe | $ 391 | 40.4% |
Revenue by Product & Service Category - Q1 FY2026
- Upper Respiratory20.4%
- Skin Health15.7%
- Healthy Lifestyle14.7%
- Pain and Sleep11%
- Digestive Health10%
- Women's Health5.7%
Revenue by Product & Service Category - Q1 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Upper Respiratory | $ 197 | 20.4% |
| Skin Health | $ 152 | 15.7% |
| Healthy Lifestyle | $ 143 | 14.7% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
3 more categories available
Sign in to unlock the full Perrigo Plc dataset.
Description of Perrigo Plc
Perrigo Company PLC is an Irish-based international pharmaceutical and consumer health company that produces a wide range of prescription drugs, generic drugs, and over-the-counter (OTC) consumer healthcare products. The company is headquartered in Dublin, Ireland, and has operations in over 30 countries around the world. Perrigo Company PLC is considered to be one of the largest manufacturers of private label OTC pharmaceutical products in the world.
History
Perrigo Company PLC was first established in 1887 as a small grocery store in Allegan, Michigan. In the early 1900s, the company expanded into the manufacture of prescription drugs and vitamins. In the 1980s, Perrigo began manufacturing private label OTC medications, which became the cornerstone of its business.
In 2013, the company acquired Elan Corporation, a biotechnology company headquartered in Irish. The acquisition allowed Perrigo to move its tax domicile to Ireland, a move that became controversial and absorbed considerable public attention.
Products
Perrigo Company PLC's products are available in various forms, including tablets, capsules, creams, liquids, sprays, and gels. The company produces a wide range of products, including prescription medications, generic drugs, and OTC consumer healthcare products. Some of its most popular brands include Prevacid (a proton pump inhibitor for the treatment of acid reflux), Rogaine (a hair growth stimulant), and Claritin (an allergy medication).
Perrigo also manufactures private label products for retailers and other companies, including Walmarts and Target store brands. Some of the most popular OTC products that the company produces for retailers include pain relievers, cold and cough medications, and vitamins.
Organizational Structure
Perrigo Company PLC's organizational structure consists of several business units, including Consumer Healthcare Americas, Consumer Healthcare International, Rx Pharmaceuticals, and Specialty Science. The Consumer Healthcare Americas unit is responsible for the development, manufacture, and distribution of OTC consumer healthcare products in North and South America. The Consumer Healthcare International unit is responsible for the development, manufacture, and distribution of OTC products in Europe, Australia, and other international markets.
The Rx Pharmaceuticals unit is responsible for the development and manufacture of prescription, generic, and specialty drugs. The Specialty Sciences unit is responsible for the development of over-the-counter and prescription healthcare products for specialty healthcare communities.
Financial Information
Perrigo Company PLC is a publicly traded company listed on the New York Stock Exchange under the symbol "PRGO." As of June 2021, the company had a market cap of approximately $5 billion. In 2020, the company reported revenue of $5.1 billion, with the majority of its revenue coming from its Consumer Healthcare business units. The company's net income in 2020 was $261 million.
Controversies
In recent years, Perrigo Company PLC has been the subject of several controversies related to its products and business practices. Some of the most notable controversies include a recall of its ranitidine product (a medication used to treat GERD and peptic ulcers) due to potential contamination, lawsuits related to the company's pricing practices, and a $1.9 billion tax liability dispute with the Irish government. The company has denied any wrongdoing in each of these cases.
History
Perrigo Company PLC was first established in 1887 as a small grocery store in Allegan, Michigan. In the early 1900s, the company expanded into the manufacture of prescription drugs and vitamins. In the 1980s, Perrigo began manufacturing private label OTC medications, which became the cornerstone of its business.
In 2013, the company acquired Elan Corporation, a biotechnology company headquartered in Irish. The acquisition allowed Perrigo to move its tax domicile to Ireland, a move that became controversial and absorbed considerable public attention.
Products
Perrigo Company PLC's products are available in various forms, including tablets, capsules, creams, liquids, sprays, and gels. The company produces a wide range of products, including prescription medications, generic drugs, and OTC consumer healthcare products. Some of its most popular brands include Prevacid (a proton pump inhibitor for the treatment of acid reflux), Rogaine (a hair growth stimulant), and Claritin (an allergy medication).
Perrigo also manufactures private label products for retailers and other companies, including Walmarts and Target store brands. Some of the most popular OTC products that the company produces for retailers include pain relievers, cold and cough medications, and vitamins.
Organizational Structure
Perrigo Company PLC's organizational structure consists of several business units, including Consumer Healthcare Americas, Consumer Healthcare International, Rx Pharmaceuticals, and Specialty Science. The Consumer Healthcare Americas unit is responsible for the development, manufacture, and distribution of OTC consumer healthcare products in North and South America. The Consumer Healthcare International unit is responsible for the development, manufacture, and distribution of OTC products in Europe, Australia, and other international markets.
The Rx Pharmaceuticals unit is responsible for the development and manufacture of prescription, generic, and specialty drugs. The Specialty Sciences unit is responsible for the development of over-the-counter and prescription healthcare products for specialty healthcare communities.
Financial Information
Perrigo Company PLC is a publicly traded company listed on the New York Stock Exchange under the symbol "PRGO." As of June 2021, the company had a market cap of approximately $5 billion. In 2020, the company reported revenue of $5.1 billion, with the majority of its revenue coming from its Consumer Healthcare business units. The company's net income in 2020 was $261 million.
Controversies
In recent years, Perrigo Company PLC has been the subject of several controversies related to its products and business practices. Some of the most notable controversies include a recall of its ranitidine product (a medication used to treat GERD and peptic ulcers) due to potential contamination, lawsuits related to the company's pricing practices, and a $1.9 billion tax liability dispute with the Irish government. The company has denied any wrongdoing in each of these cases.
Perrigo Company Plc is a prominent global healthcare organization that operates through three primary segments: Consumer Healthcare, Branded Consumer Healthcare, and Prescription Pharmaceuticals. Each segment targets distinct market needs while providing a diverse array of products and services that cater to various consumer and healthcare professional demands.
Consumer Healthcare Segment
The Consumer Healthcare Segment is primarily devoted to over-the-counter (OTC) products, which consumers can purchase without a prescription. This segment addresses an extensive range of health and wellness needs, focusing on convenience and accessibility for consumers.
Key product categories within this segment include:
1. Allergy and Cold Remedies: Products designed to alleviate symptoms associated with allergies and the common cold, including antihistamines, decongestants, and cough syrups.
2. Digestive Health Products: A range of laxatives, fiber supplements, antacids, and probiotics aimed at enhancing digestive function and relieving gastrointestinal discomfort.
3. Wound Care Treatments: This includes antiseptic solutions, dressings, and topical ointments aimed at promoting healing of minor cuts and burns.
4. Pain Relief Products: Over-the-counter pain management options, including analgesics like acetaminophen and ibuprofen that are used for temporary relief of pain and fever.
5. Oral Care Products: A variety of solutions for dental health, including toothpaste, mouth rinses, and whitening products.
The Consumer Healthcare segment serves markets in North America, Europe, and Australia, offering well-known brands such as GoodSense, MiraLAX, Rogaine, and Luvena—all designed to address everyday health concerns with effective and trusted formulations.
Branded Consumer Healthcare Segment
The Branded Consumer Healthcare Segment emphasizes brand recognition and targeted solutions for specific health conditions. This segment operates primarily in North America and Europe, providing products designed to meet distinct consumer needs and preferences.
Product offerings include:
1. Skincare Products: A portfolio of treatments for various skin conditions, including moisturizers, acne solutions, and anti-aging creams. Brands such as Clear Eyes offer specialized products for eye care, blending skincare principles with ocular health.
2. Sleep Aids: Solutions formulated to assist those struggling with sleep issues, including OTC sleep medications and natural sleep aids promoting restful sleep.
3. Women’s Health Products: A range of items addressing specific health concerns for women, such as menstrual relief, prenatal vitamins, and products targeting menopause symptoms.
4. Smoking Cessation Aids: Products designed to help users quit smoking, including nicotine replacement therapies and support materials that guide individuals through the cessation process.
Prominent brands within this segment include Wintergreen and Germolene, addressing a variety of consumer health requirements with a focus on efficacy and brand loyalty.
Prescription Pharmaceuticals Segment
The Prescription Pharmaceuticals Segment is pivotal to Perrigo’s commitment to treating various health conditions through both branded and generic prescription medications. This segment possesses a footprint that spans global markets including the Americas, Europe, and Asia Pacific.
Key areas of focus include:
1. Dermatology Products: A diverse range of topical treatments for skin conditions, including prescription creams and ointments that address eczema, psoriasis, and other dermatological disorders.
2. Oncology Products: This includes chemotherapeutic agents and supportive care medications designed for the treatment of cancer across various types and stages.
3. Ophthalmic Products: Prescription solutions for eye health, addressing conditions such as glaucoma, dry eye syndrome, and infections.
The segment also offers a portfolio of generic prescription products, which includes established brands like Fucidin (for dermatological infections), Nitrofurantoin (for urinary tract infections), and Tadalafil (for erectile dysfunction).
Additional Services
Beyond these primary segments, Perrigo extends its capabilities through various services tailored to support pharmaceutical companies and healthcare providers. These include:
- Contract Manufacturing Services: Offering expertise in the production of OTC and prescription products, enabling clients to harness Perrigo’s manufacturing and quality assurance capabilities for their product lines.
- Research and Development: A robust R&D framework allows Perrigo to innovate and develop new formulations, actively contributing to the advancement of healthcare solutions.
- Regulatory Affairs: Expertise in navigating the complex regulatory landscape ensures that products meet the necessary standards for safety and efficacy, providing support from product conception through to market entry.
Conclusion
Perrigo Company Plc stands as a comprehensive healthcare provider, blending a wide-ranging product portfolio with significant service offerings that enhance their ability to meet diverse consumer demands and support the healthcare industry effectively. By addressing a multitude of health concerns through accessible and effective solutions, Perrigo continues to fulfill its commitment to improving the health and well-being of individuals globally.
Consumer Healthcare Segment
The Consumer Healthcare Segment is primarily devoted to over-the-counter (OTC) products, which consumers can purchase without a prescription. This segment addresses an extensive range of health and wellness needs, focusing on convenience and accessibility for consumers.
Key product categories within this segment include:
1. Allergy and Cold Remedies: Products designed to alleviate symptoms associated with allergies and the common cold, including antihistamines, decongestants, and cough syrups.
2. Digestive Health Products: A range of laxatives, fiber supplements, antacids, and probiotics aimed at enhancing digestive function and relieving gastrointestinal discomfort.
3. Wound Care Treatments: This includes antiseptic solutions, dressings, and topical ointments aimed at promoting healing of minor cuts and burns.
4. Pain Relief Products: Over-the-counter pain management options, including analgesics like acetaminophen and ibuprofen that are used for temporary relief of pain and fever.
5. Oral Care Products: A variety of solutions for dental health, including toothpaste, mouth rinses, and whitening products.
The Consumer Healthcare segment serves markets in North America, Europe, and Australia, offering well-known brands such as GoodSense, MiraLAX, Rogaine, and Luvena—all designed to address everyday health concerns with effective and trusted formulations.
Branded Consumer Healthcare Segment
The Branded Consumer Healthcare Segment emphasizes brand recognition and targeted solutions for specific health conditions. This segment operates primarily in North America and Europe, providing products designed to meet distinct consumer needs and preferences.
Product offerings include:
1. Skincare Products: A portfolio of treatments for various skin conditions, including moisturizers, acne solutions, and anti-aging creams. Brands such as Clear Eyes offer specialized products for eye care, blending skincare principles with ocular health.
2. Sleep Aids: Solutions formulated to assist those struggling with sleep issues, including OTC sleep medications and natural sleep aids promoting restful sleep.
3. Women’s Health Products: A range of items addressing specific health concerns for women, such as menstrual relief, prenatal vitamins, and products targeting menopause symptoms.
4. Smoking Cessation Aids: Products designed to help users quit smoking, including nicotine replacement therapies and support materials that guide individuals through the cessation process.
Prominent brands within this segment include Wintergreen and Germolene, addressing a variety of consumer health requirements with a focus on efficacy and brand loyalty.
Prescription Pharmaceuticals Segment
The Prescription Pharmaceuticals Segment is pivotal to Perrigo’s commitment to treating various health conditions through both branded and generic prescription medications. This segment possesses a footprint that spans global markets including the Americas, Europe, and Asia Pacific.
Key areas of focus include:
1. Dermatology Products: A diverse range of topical treatments for skin conditions, including prescription creams and ointments that address eczema, psoriasis, and other dermatological disorders.
2. Oncology Products: This includes chemotherapeutic agents and supportive care medications designed for the treatment of cancer across various types and stages.
3. Ophthalmic Products: Prescription solutions for eye health, addressing conditions such as glaucoma, dry eye syndrome, and infections.
The segment also offers a portfolio of generic prescription products, which includes established brands like Fucidin (for dermatological infections), Nitrofurantoin (for urinary tract infections), and Tadalafil (for erectile dysfunction).
Additional Services
Beyond these primary segments, Perrigo extends its capabilities through various services tailored to support pharmaceutical companies and healthcare providers. These include:
- Contract Manufacturing Services: Offering expertise in the production of OTC and prescription products, enabling clients to harness Perrigo’s manufacturing and quality assurance capabilities for their product lines.
- Research and Development: A robust R&D framework allows Perrigo to innovate and develop new formulations, actively contributing to the advancement of healthcare solutions.
- Regulatory Affairs: Expertise in navigating the complex regulatory landscape ensures that products meet the necessary standards for safety and efficacy, providing support from product conception through to market entry.
Conclusion
Perrigo Company Plc stands as a comprehensive healthcare provider, blending a wide-ranging product portfolio with significant service offerings that enhance their ability to meet diverse consumer demands and support the healthcare industry effectively. By addressing a multitude of health concerns through accessible and effective solutions, Perrigo continues to fulfill its commitment to improving the health and well-being of individuals globally.